| <p>Vaxfab Enterprises Limited will seek to augment its financial resources through a fundraising exercise involving the issuance of equity shares, convertible instruments, or other securities via preferential allotment, right issue, QIP’s, ADR GDR, FCCB or any other method or combination thereof, the company said in a filing with the BSE Limited and The Calcutta Stock Exchange Limited on September 25, 2026. The company’s trading window for securities has been closed from September 25, 2026, and will remain so until 48 hours after the conclusion of the board meeting scheduled for October 1, 2026.</p> |